Skip to content

Buying a Pharmacy

Financial Due Diligence When Buying a Pharmacy

11 November 2026 · 9 min read

Get in touch

What financial due diligence on a pharmacy actually means

It isn't reading the profit and loss account and checking the number's positive. It's proving three things before you commit: that the NHS income is real and recurring, that the gross margin holds up across the Drug Tariff's quarterly price changes, and that the accounts are clean. A due diligence list written for a shop or a trade business misses the NHS risks sitting behind the headline profit.

We run it in this order: income, margin, VAT, the balance sheet and staff costs, then regulatory transfer. The buying a pharmacy UK checklist has the whole purchase in order, and share vs asset purchase for a pharmacy covers the structure; both lean on the checks here.

Verifying the income: FP34 history and the NHSBSA payment lag

A pharmacy's main income is reimbursement and remuneration under the Community Pharmacy Contractual Framework, so the documents that prove it are NHSBSA's, not till receipts.

Each month's prescriptions go to NHSBSA with the FP34C declared by the 5th of the next month. NHSBSA pays an estimated 100% advance (the declared activity times the average item value, less prescription charges collected) around the 10th, then pays any balance on reconciliation two months after submission; if the advance was too high, the difference comes out of the next advance (Drug Tariff Part I Clause 5C, England). Declare late and the advance moves to the next payment run, or is lost to the reconciliation. So the accounts at any date carry a debtor for reconciliations still to come, and a conventional P&L doesn't show that timing without adjustment.

What to request

  • At least 24 months of FP34 submission schedules: item count, declared value and month submitted.
  • The matching NHSBSA payment remittances, to set what was claimed against what was paid.
  • A reconciliation of the remittance total to the income line in each year's statutory accounts.

The red flags

  • Income in the P&L that can't be traced to an NHSBSA remittance.
  • Item volumes that jump in the months before the sale with no GP or population reason.
  • Gaps in the FP34 history that the dispensing system's audit trail can't explain.

The FP34 cash flow estimator shows when the advance and reconciliation land against your wholesaler and wage payments for a given item volume, which tells you how much working capital you need on top of the price.

Source document What it proves Pharmacy-specific check
FP34 submission schedules Item volume and declared value submitted each month Trend consistency; any volume spike near the sale date
NHSBSA remittance statements Actual payment received, including advance on account Reconciles to P&L income; shows each advance and the reconciliation two months after submission
VAT returns Output tax and input tax split by period Zero-rated dispensing turnover consistent with FP34 volume
Statutory accounts (two or three years) Profit, balance sheet, debtors, stock NHSBSA debtor matches the reconciliations still due at the year end; no unexplained accruals
Payroll records Staff headcount and cost run-rate Employer NIC at 15% above £5,000 secondary threshold (current rate from April 2025); no off-payroll risk

The margin story: Category M and Drug Tariff

Under the Drug Tariff, reimbursement prices are set centrally and each item is paid at the price listed for the month it's dispensed. So the margin in the year the seller is marketing reflects that year's prices, not a margin you can count on.

Category M covers generics that are "readily available as licensed generic medicines" (Drug Tariff Part VIIIA). DHSC sets their prices from suppliers' price information and adjusts them each quarter in light of the medicine margin survey: when the sector has earned more than the contract funds, later quarters' prices are set lower (the clawback), and an under-delivery is put right with higher ones. Nothing already dispensed is repriced, so year one of your review can look different from year three because the prices changed, not the business. For 2026/27, up to £239 million of historic net over-delivery is written off and no price adjustments will recover what's left from 2025/26.

What the analysis needs to cover

  • Gross margin as a percentage of dispensing revenue over two to three years, not one.
  • Margin quarter by quarter in the management accounts, so you can see how it moved as Category M prices changed.
  • How much of the dispensing is Category M against branded or other lines (the more Category M, the more the margin swings).
  • Pharmacy First and similar service income as its own line (see Pharmacy First income accounting), because its margin behaves differently from dispensing.

How tariff changes reach the P&L is in drug tariff changes explained and category M clawbacks explained.

The VAT mix check

NHS-dispensed prescription drugs are zero-rated; medicines sold over the counter are, in HMRC's words, "a separate, standard-rated supply". Zero-rated dispensing is still taxable turnover, so an NHS pharmacy has to register once it goes over £90,000 unless HMRC has granted exemption from registration (and then it reclaims no input VAT). Confirm which applies to the target.

The mix decides two things: how much input VAT comes back, and which retail scheme fits. HMRC says "Most group 12 goods dispensed on prescription are standard-rated when bought by the chemist but zero-rated when supplied to the patient" (VAT Notice 727 s8.2), which is why direct calculation schemes and apportionment scheme 1 need the Retail Chemist Adjustment. Do pharmacies pay VAT explains how it works. A pharmacy that used the wrong scheme, or skipped the adjustment, may have over- or underpaid, and in a share deal that stays with the company.

What to check

  • The retail scheme in use, whether it suits the dispensing-to-shelf split and is within its turnover limit (£1 million for apportionment scheme 1 and direct calculation scheme 1, £130 million for the scheme 2 versions), and whether the Retail Chemist Adjustment is made where it's required.
  • Whether the last four years' VAT returns reconcile to the scheme calculations (four years is the standard window; deliberate errors can go back further).
  • Private services or clinic income, which can be exempt or standard-rated rather than zero-rated (see VAT on private services and Pharmacy First). If it's been treated wrongly, the liability builds up.
  • Partial exemption, if there are exempt supplies: the business is treated as fully taxable only if exempt input tax is no more than £625 a month on average and no more than half of all input tax, and both conditions must be met (VAT Notice 706).

In an asset deal, a VAT liability stays with the seller, and the transfer of a going concern (TOGC) rules keep VAT off the price, but only when every condition in VAT Notice 700/9 holds:

  • the assets come with the business, and you intend to carry on the same kind of business;
  • if they're VAT registered, you're registered already or become so through the transfer;
  • any part you buy can operate on its own, and the sale isn't one of a series of immediately consecutive transfers;
  • there's no significant break in normal trading before or straight after it;
  • where the premises would be standard-rated (they've opted to tax, or it's the freehold of a building under 3 years old), you've opted to tax, notified HMRC by the relevant date and told them your option isn't disapplied.

Miss one and VAT is due on the assets at their usual rates. How VAT risk is shared at deal level follows the structure (see share vs asset purchase).

Balance sheet, stock and staff costs

Dispensing stock valuation

Stock is held at cost, but the Drug Tariff prices you're paid at move. When DHSC sets a lower Category M price for a later quarter, stock bought at the old price may be carried at more than it will now earn. Check how the seller values closing stock and whether that fits the Drug Tariff prices at the balance sheet date.

Staff costs and the current employer NIC rate

Model the payroll you're buying (dispensers, counter staff, technicians, a superintendent) at current rates. Employer NIC is 15% above a £5,000 secondary threshold from April 2025, so management accounts still built on the old 13.8% above £9,100 understate the cost.

The Employment Allowance takes up to £10,500 a year off employer NIC. gov.uk excludes businesses doing more than half their work in the public sector, but HMRC's further guidance says "Independent pharmacies conducting a business, including over the counter sales as well as dispensing NHS prescriptions, are entitled to claim the Employment Allowance." The usual tests still apply (a sole director who's the only employee above the threshold can't claim; one claim per group, against one payroll). The one that catches buyers: if you take the business over part-way through a tax year, what's left of that year's allowance can't be set against the NIC on the staff who come with it, TUPE transfers included, so model the rest of that year's payroll for them without it.

Corporation tax position and associated companies

If the seller trades through a company, check its corporation tax position: 25% on profits over £250,000, 19% up to £50,000, Marginal Relief between. Both limits are shared between a company and its associates (a company with three associated companies gets a quarter of each), so a seller with several pharmacy companies may have used up the small-profits headroom even if the target's own profit looks modest. In a share purchase, unprovided deferred tax and any open HMRC enquiries come with the company; scope them jointly with the legal due diligence.

The pharmacy purchase affordability calculator shows whether profit after current payroll costs and corporation tax covers the finance repayments you're being quoted.

Add the purchase price, deposit, loan terms and projected profit to see the monthly repayment, the post-tax cash cover and the stamp duty or SDLT on a share deal against an asset deal.

Calculator

Pharmacy Purchase Affordability Calculator

Enter the purchase price, deposit, loan terms and projected pharmacy profit to see your estimated loan repayments, how well trading cash flow covers the debt, and the acquisition tax cost for a share deal versus an asset deal. Every figure already in the boxes is an example, so replace it with your own; the result on your deal depends on how it's structured.

£

The agreed headline price for the pharmacy. Enter the actual figure from your heads of terms.

£

The amount you are putting in from your own funds. The rest is assumed to be financed by a commercial loan.

The term your lender offers. Shorter terms mean higher repayments but less total interest.

The rate quoted by the lender. The rate you are offered depends on lender, term and loan-to-value.

£

The part of the price that buys land or buildings: a freehold, or what you pay for a lease. Leave at 0 if no property is being bought. SDLT is charged on this figure only, never on goodwill or the NHS contract.

£

Only if you're taking a new lease of the premises. SDLT is due on the rent's net present value at 1% from £150,001 to £5 million and 2% above. HMRC's SDLT calculator works the figure out from the rent and the term.

£

The adjusted EBITDA or trading profit you expect after your salary, before loan interest and tax. The tool takes the first year's interest off before working out corporation tax.

Your result

Your answer's ready. Press below to see it.

The DD checklist: workstreams at a glance

Workstream Documents to request Why it matters Pharmacy-specific red flag
Income verification 24+ months FP34 schedules; NHSBSA remittances Confirms NHS income is real, recurring and reconcilable to accounts P&L income not traceable to NHSBSA remittance; item-volume spike near sale
Margin story Three years management accounts; Category M schedule; Drug Tariff mix by volume Single-year margin is unreliable because DHSC resets Category M prices each quarter Only one year of margin data; no quarter-by-quarter margin in the accounts
VAT position VAT returns four years; retail scheme workings; private services income analysis Wrong retail scheme or mis-classified private services creates inherited liability in a share deal Scheme not appropriate for actual zero-rated/standard-rated split; Retail Chemist Adjustment missing; private services misclassified
Balance sheet and stock Stock valuation policy; aged creditors and debtors; any HMRC correspondence Dispensing stock may be overvalued after a lower Category M price takes effect; deferred liabilities are inherited in share deals Stock carried above what it will now earn; unexplained accruals or provisions
Staff costs Payroll records; P60s and P11Ds for last two years; Employment Allowance claim history (and whether any is left for the year you take over) Run-rate must reflect 15% employer NIC above £5,000 threshold (from April 2025) Payroll modelled at old 13.8% rate; Employment Allowance not claimed; off-payroll locum risk
Regulatory transfer NHS contract documentation; the premises entry in the GPhC register; superintendent pharmacist (Medicines Act 1968 s71) Contract does not pass automatically; check the premises registration with your solicitor (Medicines Act 1968 ss74A, 74B) NHS England's approval (asset deal) not made a condition precedent; superintendent post unfilled at completion

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

Regulatory and contract DD: the transfer mechanics

The NHS contract doesn't assign itself on a sale. Under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, buying the assets needs NHS England's approval of a change of ownership application (regulation 26) before you can operate under the contract. Buying the company leaves it on the pharmaceutical list, but it has to tell NHS England within 30 days of new directors or a new superintendent (Schedule 4, paragraph 32). The risk is timing: if approval isn't a condition precedent, you can complete and then find you can't dispense under the contract on day one.

The premises also need an entry in the GPhC register, which depends on the applicant lawfully running a retail pharmacy business there, or being about to (Medicines Act 1968 ss74A, 74B), and a company needs a superintendent pharmacist (s71) in place before or at completion. If you're a pharmacist buying through your own company, that can be you. The buying checklist sets out who can own a pharmacy and the order of the NHS steps. We deal with the ownership and registration mechanics only, not clinical or professional matters.

What a specialist checks before you exchange

Generic due diligence rarely reads the documents wrongly. It just never asks for the right ones. Before exchange, we reconcile the NHSBSA remittance trail to the P&L period by period, normalise adjusted EBITDA for Category M swings and owner costs that won't transfer (so the price is measured against the business you're buying, not the one being marketed), check the retail scheme against the actual sales data, and model the cash cycle after completion at current NIC rates and the FP34 timetable.

The buying a pharmacy hub sets out how we support buyers at each stage, and the pharmacy purchase accounting service covers the due diligence and post-completion work. To see what the business can borrow and repay, start with the pharmacy purchase affordability calculator; for when the NHS money lands against your outgoings, the FP34 cash flow estimator.

Frequently asked questions

It checks that the NHS income is real and recurring (FP34 history against NHSBSA remittances), that the gross margin holds up over several years of Category M and Drug Tariff changes, that the VAT retail scheme fits the sales mix, that staff costs reflect employer NIC at 15% above the £5,000 secondary threshold, and that the balance sheet, stock included, is clean. Regulatory transfer (the NHS contract and the premises entry in the GPhC register) runs alongside it as a deal-critical condition.

Request at least 24 months of FP34 submission schedules and the matching NHSBSA payment remittances. Cross-reference the submitted item count and declared value against the remittance statements. Income that appears on the P&L but cannot be reconciled to an NHSBSA remittance is a red flag.

Because Drug Tariff prices are set centrally and DHSC resets Category M prices each quarter. If pharmacies as a whole have been paid more margin than the contract funds, later quarters' prices are set lower to recoup it, so a margin that looks strong in one year can be eroded in the next by lower prices on what you dispense then. Margin variance over at least two to three years, not a snapshot figure, is the meaningful check.

No. Under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, an asset deal needs NHS England's approval: you apply to be included in the pharmaceutical list in the seller's place (a change of ownership application, regulation 26). The contract does not pass to the buyer by operation of law. In a share deal the company stays on the list, but it has to tell NHS England within 30 days of any change to its directors or superintendent.

Confirm which VAT retail scheme the pharmacy uses to split zero-rated NHS dispensing from standard-rated OTC sales, verify the scheme is appropriate for the actual sales mix and that the Retail Chemist Adjustment is made where the scheme needs it, and check whether VAT returns reconcile to the scheme outputs. A misapplied scheme can create historic underpayments or overpayments that become the buyer's liability in a share deal.

It depends on how quickly the seller can produce the FP34 schedules, VAT returns, payroll records and accounts pack, and on how complex the business is. A single-site asset deal with clean records is quicker than a multi-site share deal with history. Build it into the time between heads of terms and exchange rather than assuming a fixed number of weeks.

Related reading

Need help with your pharmacy finances?

Tell us about your situation and we will come back within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)